---
title: "Neochem Bio Solutions Ltd (NEOCHEM) — Share Price, Financials & Analysis"
symbol: "NEOCHEM"
company: "Neochem Bio Solutions Ltd"
canonical: "https://tapetide.com/stocks/NEOCHEM"
isin: "INE21UM01018"
nse_symbol: "NEOCHEM"
sector: "Chemicals"
industry: "Specialty Chemicals"
market_cap_cr: 171.21
generated_at: "2026-09-13T18:59:19.629Z"
---

# Neochem Bio Solutions Ltd (NEOCHEM)

Canonical page: https://tapetide.com/stocks/NEOCHEM

## Company

- **NSE Symbol:** NEOCHEM
- **ISIN:** INE21UM01018
- **Sector:** Chemicals
- **Industry:** Specialty Chemicals
- **Macro Sector:** Commodities
- **Stock Type:** EQUITY
- **Listed Since:** 2025-12-09
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** neochem.in

## About

Incorporated in 2006, Neochem Bio Solutions Ltd. is engaged in the business of manufacturing of specialty performance chemicals.[1]

## Latest Price

- **Price:** ₹102.15
- **Change:** -1.35 (-1.3%)
- **Open:** ₹98
- **Day High:** ₹104.3
- **Day Low:** ₹98
- **Previous Close:** ₹103.5
- **Volume:** 18000
- **As Of:** 2026-09-11T09:59:01+00:00

## Key Fundamentals

Observed at 2026-09-11T04:34:13.724288Z.

- **Market Cap:** ₹171.21 Cr
- **Classification:** SME
- **P/E (reported):** 0
- **Book Value:** ₹46.05
- **Price to Book:** 2.25
- **Dividend Yield:** 0%
- **ROE:** 39.24%
- **ROCE:** 39.4%
- **Debt to Equity:** 0.23
- **Revenue (yearly):** ₹86.2 Cr
- **Net Income:** ₹7.8 Cr
- **EBITDA:** ₹15.1 Cr
- **52-Week High:** ₹121
- **52-Week Low:** ₹63
- **RSI (14):** 60.59

## Key Insights

### Strengths

- Company has reduced debt.
- Company has a good return on equity (ROE) track record: 3 Years ROE 28.8%

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 161 days.
- Working capital days have increased from 77.8 days to 164 days

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| cash flow growth | 32.14% | 450% | -99.88% |
| ebitda margin growth | 58.55% | — | — |
| net income growth | 333.33% | 122% | — |
| revenue growth | 39.03% | 32% | — |
| roce | 117.68% | — | — |
| roe | 161.43% | — | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2025 | Mar 2026 |
| --- | --- | --- |
| Sales | 47 | 65 |
| Expenses | 39 | 54 |
| Operating Profit | 8 | 11 |
| OPM % | 17 | 17 |
| Other Income | 2 | 1 |
| Interest | 2 | 2 |
| Depreciation | 1 | 1 |
| Profit before tax | 7 | 10 |
| Tax % | 24 | 30 |
| Net Profit | 6 | 7 |
| EPS in Rs | 8.31 | 4.01 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Sales | 49 | 48 | 61 | 84 | 111 |
| Expenses | 45 | 44 | 55 | 71 | 91 |
| Operating Profit | 4 | 4 | 6 | 13 | 20 |
| OPM % | 7 | 9 | 10 | 15 | 18 |
| Other Income | 0 | 1 | 1 | 2 | 2 |
| Interest | 1 | 2 | 3 | 4 | 4 |
| Depreciation | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 1 | 2 | 3 | 10 | 17 |
| Tax % | 25 | 28 | 31 | 25 | 30 |
| Net Profit | 1 | 1 | 2 | 7 | 12 |
| EPS in Rs | 3.23 | 2.1 | 2.89 | 11.15 | 7.03 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Equity Capital | 3 | 5 | 7 | 7 | 17 |
| Reserves | 1 | 3 | 6 | 13 | 62 |
| Borrowings | 23 | 26 | 33 | 36 | 18 |
| Other Liabilities | 19 | 16 | 18 | 24 | 20 |
| Total Liabilities | 46 | 51 | 63 | 79 | 117 |
| Fixed Assets | 12 | 15 | 19 | 19 | 20 |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 6 |
| Other Assets | 34 | 36 | 45 | 60 | 91 |
| Total Assets | 46 | 51 | 63 | 79 | 117 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -1 | -1 | -1 | 2 | -17 |
| Cash from Investing Activity | -3 | -3 | 12 | -1 | -9 |
| Cash from Financing Activity | 4 | 4 | -11 | -1 | 26 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | -4 | -4 | 11 | 1 | -19 |
| CFO/OP | -36 | -23 | -10 | 23 | -70 |

### Ratios

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Debtor Days | 102 | 107 | 100 | 110 | 161 |
| Inventory Days | 141 | 173 | 172 | 157 | 143 |
| Days Payable | 186 | 155 | 142 | 111 | 56 |
| Cash Conversion Cycle | 58 | 125 | 131 | 156 | 247 |
| Working Capital Days | 17 | 19 | 30 | 39 | 164 |
| ROCE % | — | 12 | 14 | 26 | 28 |

## Shareholding Pattern

### Quarterly

| Category | Dec 2025 | Mar 2026 |
| --- | --- | --- |
| Promoters | 91.12% | 66.72% |
| FIIs | 1.99% | 0.18% |
| DIIs | 0% | 15.82% |
| Government | 0% | 0% |
| Public | 0% | 10.93% |
| Others | 6.89% | 6.35% |
| No. of Shareholders | 14 | 406 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 10 / 9 / 0

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 99.11 | Buy |
| EMA (10) | 99.79 | Buy |
| SMA (20) | 97.54 | Buy |
| EMA (20) | 97.78 | Buy |
| SMA (50) | 93.96 | Buy |
| EMA (50) | 95.36 | Buy |
| SMA (100) | 93.68 | Buy |
| EMA (100) | 93 | Buy |
| SMA (200) | — | Neutral |
| EMA (200) | — | Neutral |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 58.2 | Neutral |
| MACD (12,26,9) | 2.25 | Buy |
| Stochastic (14,3,3) | 66.22 | Neutral |
| ADX (14) | 17.92 | Neutral |
| Williams %R (14) | -49.27 | Neutral |
| ATR (14) | 5.46 | High Volatility |
| ROC (12) | 7.53 | Buy |
| Stoch RSI (14) | 51.64 | Neutral |
| UO (7,14,28) | 50.29 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9 April 2026 - Promoters disclosed no encumbrance on Neochem shares during FY 2025-26. | [Updates 9 April 2026 - Promoters disclosed no encumbrance on Neochem shares during FY 2025-26.](https://nsearchives.nseindia.com/corporate/NEOCHEM_09042026143703_NSE_Intimation_31_4__Signed.pdf) |
| 6 April 2026 - Neochem will exhibit at China Interdye 2026 in Shanghai, April 15-17, 2026, for global expansion. | [General Updates 6 April 2026 - Neochem will exhibit at China Interdye 2026 in Shanghai, April 15-17, 2026, for global expansion.](https://nsearchives.nseindia.com/corporate/NEOCHEM_06042026163518_NSE_Intimation_for_Exhibition_Reg_30.pdf) |
| 5 March 2026 - Investor presentation: Red Herring Prospectus filed for proposed IPO; FY25 revenue ₹8,400 Lakhs; 22,000 MTPA capacity. | [Investor Presentation 5 March 2026 - Investor presentation: Red Herring Prospectus filed for proposed IPO; FY25 revenue ₹8,400 Lakhs; 22,000 MTPA capacity.](https://nsearchives.nseindia.com/corporate/NEOCHEM_05032026180024_Investors_Presentation.pdf) |
| 5 March 2026 - Analyst/Institutional investor meeting on March 10, 2026 at Taj Santacruz, Mumbai (9:00 AM–6:00 PM); no UPSI. | [Analysts/Institutional Investor Meet/Con. Call Updates 5 March 2026 - Analyst/Institutional investor meeting on March 10, 2026 at Taj Santacruz, Mumbai (9:00 AM–6:00 PM); no UPSI.](https://nsearchives.nseindia.com/corporate/NEOCHEM_05032026175540_Intimation_investors_meet_signed.pdf) |
| 30 March 2026 - Trading window closed from April 1, 2026 until 48 hours after audited results for year ended March 31, 2026. | [Trading Window 30 March 2026 - Trading window closed from April 1, 2026 until 48 hours after audited results for year ended March 31, 2026.](https://nsearchives.nseindia.com/corporate/NEOCHEM_30032026174432_Trading_Window_Closure.pdf) |
| 30 Jul - SDD compliance certificate submitted for quarter ended 30 June 2026. | [Structural Digital Database 30 Jul - SDD compliance certificate submitted for quarter ended 30 June 2026.](https://nsearchives.nseindia.com/corporate/NEOCHEM_30072026152939_SDD_FINAL_3007026.pdf) |
| 29 January 2026 - Quarterly investor complaints statement for Dec 31, 2025: one received, one unresolved. | [Integrated Filing- Governance 29 January 2026 - Quarterly investor complaints statement for Dec 31, 2025: one received, one unresolved.](https://nsearchives.nseindia.com/corporate/NEOCHEM_29012026143040_INVESTORs_31122025.pdf) |
| 29 Aug - Neochem Bio Solutions appointed Siddharth Raj as Business Head (Textiles) Corporate Accounts, effective August 29, 2026. | [Change in Management 29 Aug - Neochem Bio Solutions appointed Siddharth Raj as Business Head (Textiles) Corporate Accounts, effective August 29, 2026.](https://nsearchives.nseindia.com/corporate/NEOCHEM_29082026163940_Regulation_30_Intimation__Appointment_SMP.pdf) |
| 28 Jul - Promoter Swapnil Rameshbhai Makati bought 6,000 shares on 28.07.2026, raising holding to 54.70%. | [Updates 28 Jul - Promoter Swapnil Rameshbhai Makati bought 6,000 shares on 28.07.2026, raising holding to 54.70%.](https://nsearchives.nseindia.com/corporate/NEOCHEM_28072026173315_Form_C_28072026.pdf) |
| 27 May 2026 - FY26 revenue rose 32% to ₹110.7 crore; EBITDA reached ₹22.6 crore and PAT ₹12 crore. | [Analysts/Institutional Investor Meet/Con. Call Updates 27 May 2026 - FY26 revenue rose 32% to ₹110.7 crore; EBITDA reached ₹22.6 crore and PAT ₹12 crore.](https://nsearchives.nseindia.com/corporate/NEOCHEM_27052026183143_Earning_call_intimation_-_NSE-signed.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2026 from nse](https://archives.nseindia.com/annual_reports/SME_AR_30683_NEOCHEM_2025_2026_A_5560400_26082026193421.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:59:19.629Z.